Recursion Pharmaceuticals, Inc. RXRX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax by Product | |||||
| Grant revenue | $426K+21.4% | $351K-49.8% | $699K+331% | $162K-9.0% | |
| Operating revenue | $74.26M+27.0% | $58.49M+33.3% | $43.88M+10.6% | $39.68M+297% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Recursion Pharmaceuticals, Inc. break its business down?
- Recursion Pharmaceuticals, Inc. (RXRX) reports revenue from contract with customer, excluding assessed tax by product across 2 parts — Grant revenue and Operating revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Recursion Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Recursion Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
